Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Receptor is raising $10,000,000.00 in new funding. Sources indicate as part of senior management President, Mark Theeuwes played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Receptor
Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications. The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptors patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism.

To learn more about Receptor, visit http://www.receptorlife.com/

Contact:
Mark Theeuwes, President
206-483-2730
https://www.linkedin.com/in/mark-theeuwes-b44ab98/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved